The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.
Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
Open accessAbstract
Glioblastomas are lethal cancers characterized by florid angiogenesis promoted in part by glioma stem cells (GSCs). Because hypoxia regulates angiogenesis, we examined hypoxic responses in GSCs. We now demonstrate that hypoxia-inducible factor HIF2alpha and multiple HIF-regulated genes are preferentially expressed in GSCs in comparison to non-stem tumor cells and normal neural progenitors. In tumor specimens, HIF2alpha colocalizes with cancer stem cell markers. Targeting HIFs in GSCs inhibits self-renewal, proliferation, and survival in vitro, and attenuates tumor initiation potential of GSCs in vivo. Analysis of a molecular database reveals that HIF2A expression correlates with poor glioma patient survival. Our results demonstrate that GSCs differentially respond to hypoxia with distinct HIF induction patterns, and HIF2alpha might represent a promising target for antiglioblastoma therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Since HIF-2α is strongly expressed in the cytoplasm of NB tumor cells at physiological oxygen levels (5% O2), this could suggest additional largely unexplored functions of HIF-2α in the cytoplasm, independent of HIF-1β-dependent transcription, such as regulation of mRNA translation [9,43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In NB clinical specimens, HIF-1α expression negatively correlates with the presence of blood vessels indicating that HIF-1α is expressed exclusively in hypoxic cells [43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, HIF-2α is located in dense clusters of cells adjacent to blood vessels, referred to as the perivascular niche, which have a neural crest-like phenotype, and are HIF-1α negative, suggesting they are not hypoxic [43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, treatment with PT2385 had no effect on tumor growth, did not impact transcription of HIF target genes and did not modulate chemotherapy response [43].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [43]
Experimental — accuracy not yet measuredIn the citing paper
“Given that HIF-2α is an important transcription factor in cancer progression and leads to poor prognosis69,70”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [70]
In the citing paper
“Hypoxia was first shown to induce the CSC phenotype in glioma [77] and, subsequently, in breast cancer [78, 79], in a HIF-dependent manner.”
From The hypoxic tumor microenvironment: A driving force for breast cancer progression (2016) · cites this paper as [77]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C. E., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,564
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,517
Self-citationHypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma
Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., Vitis, S. D., Fiocco, R., Foroni, C., DiMeco, F., & Vescovi, A. L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1364 · Cited by 2,570
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,262
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D. K., Black, K. L., & Yu, J. S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-67 · Cited by 1,844
Cancerous stem cells can arise from pediatric brain tumors
Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M. D., Geschwind, D. H., Bronner-Fraser, M. E., & Kornblum, H. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036535100 · Cited by 1,842
Cited by
Sorted by citations
Items 101–200 of 1,000
Combination therapy to checkmate Glioblastoma: clinical challenges and advances
Ghosh, D., Nandi, S., & Bhattacharjee, S. (2018) · Clinical and Translational Medicine · doi:10.1186/s40169-018-0211-8 · Cited by 233
Cancer stem cells: landscape, challenges and emerging therapeutic innovations
Lee, H., Kim, B., Park, J., Park, S., Yoo, G., Yum, S., Kang, W., Lee, J., Youn, H., & Youn, B. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02360-2 · Cited by 247
Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER
van den Beucken, T., Koch, E., Chu, K., Rupaimoole, R., Prickaerts, P., Adriaens, M. E., Voncken, J. W., Harris, A. L., Buffa, F. M., Haider, S. A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6203 · Cited by 229
Xu, J., Zhang, J., Zhang, Z., Gao, Z., Qi, Y., Qiu, W., Pan, Z., Guo, Q., Li, B., Zhao, S., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03664-1 · Cited by 233
Self-citationCancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma
Biserova, K., Jakovļevs, A., Uljanovs, R., & Štrumfa, I. (2021) · Cells · doi:10.3390/cells10030621 · Cited by 239
Cojoc, M., Peitzsch, C., Kurth, I., Trautmann, F., Kunz‐Schughart, L. A., Телегеев, Г. Д., Stakhovsky, E. A., Walker, J. R., Simin, K. J., Lyle, S. R., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1924 · Cited by 225
miR-182 integrates apoptosis, growth, and differentiation programs in glioblastomaPreprint
Kouri, F. M., Hurley, L., Daniel, W. L., Day, E. S., Hua, Y., Hao, L., Peng, C., Merkel, T. J., Queisser, M. A., Ritner, C., et al. (2015) · Genes & Development · doi:10.1101/gad.257394.114 · Cited by 226
Schwab, L. P., Peacock, D. L., Majumdar, D., Ingels, J. F., Jensen, L. C., Smith, K., Cushing, R. C., & Seagroves, T. N. (2012) · Breast Cancer Research · doi:10.1186/bcr3087 · Cited by 220
The softness of tumour-cell-derived microparticles regulates their drug-delivery efficiency
Liang, Q., Bie, N., Yong, T., Tang, K., Shi, X., Wei, Z., Jia, H., Zhang, X., Zhao, H. Y., Huang, W., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0405-4 · Cited by 225
Applications of Surface Modification Technologies in Nanomedicine for Deep Tumor Penetration
Li, Z., Shan, X., Chen, Z., Gao, N., Zeng, W., Zeng, X., & Mei, L. (2020) · Advanced Science · doi:10.1002/advs.202002589 · Cited by 221
Self-citationThe cancer stem cell niche: cross talk between cancer stem cells and their microenvironment
Ye, J., Wu, D., Wu, P., Chen, Z., & Huang, J. (2014) · Tumor Biology · doi:10.1007/s13277-013-1561-x · Cited by 224
Glioma stem cells and their roles within the hypoxic tumor microenvironment
Boyd, N., Tran, A. N., Bernstock, J. D., Etminan, T., Jones, A. B., Gillespie, G. Y., Friedman, G. K., & Hjelmeland, A. B. (2020) · Theranostics · doi:10.7150/thno.41692 · Cited by 221
Self-citationSaxena, K., & Jolly, M. K. (2019) · Biomolecules · doi:10.3390/biom9080339 · Cited by 223
Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM
Florczyk, S. J., Wang, K., Jana, S., Wood, D. L., Sytsma, S. K., Sham, J. G., Kievit, F. M., & Zhang, M. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.034 · Cited by 213
Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Shanmugam, M. K., Warrier, S. R., Kumar, A. P., Sethi, G., & Arfuso, F. (2017) · Current Vascular Pharmacology · doi:10.2174/1570161115666170713094319 · Cited by 214
Cui, C., Wong, C. C., Kai, A. K., Ho, D. W., Lau, E. Y.-T., Tsui, Y., Chan, L., Cheung, T. T., Chok, K., Chan, A. C. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313264 · Cited by 210
Mathieu, J., Zhou, W., Xing, Y., Sperber, H., Ferreccio, A., Agoston, Z., Kuppusamy, K. T., Moon, R. T., & Ruohola‐Baker, H. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.012 · Cited by 217
Cancer cell differentiation heterogeneity and aggressive behavior in solid tumors
Jögi, A., Vaapil, M., Johansson, M., & Påhlman, S. (2012) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2012.659294 · Cited by 209
López de Andrés, J., Griñán-Lisón, C., Jiménez, G., & Marchal, J. A. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00966-3 · Cited by 207
Purine synthesis promotes maintenance of brain tumor initiating cells in glioma
Wang, X., Yang, K., Xie, Q., Wu, Q., Mack, S. C., Shi, Y., Kim, L. J. Y., Prager, B. C., Flavahan, W. A., Liu, X., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4537 · Cited by 206
Self-citationCancer cell plasticity: Impact on tumor progression and therapy response
da Silva-Diz, V., Lorenzo-Sanz, L., Bernat‐Peguera, A., Lopez-Cerda, M., & Muñoz, P. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.08.009 · Cited by 217
The hypoxic microenvironment: A determinant of cancer stem cell evolution
Carnero, A., & LLeonart, M. E. (2016) · BioEssays · doi:10.1002/bies.201670911 · Cited by 204
Elevated invasive potential of glioblastoma stem cells
Cheng, L., Wu, Q., Guryanova, O. A., Huang, Z., Huang, Q., Rich, J. N., & Bao, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.123 · Cited by 200
Self-citationCancer Stem Cells and Chemosensitivity
Maugeri‐Saccà, M., Vigneri, P. G., & Maria, R. D. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2538 · Cited by 200
Brain tumor stem cells: Molecular characteristics and their impact on therapy
Schonberg, D. L., Lubelski, D., Miller, T. E., & Rich, J. N. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.06.004 · Cited by 204
Self-citationMineo, M., Ricklefs, F. L., Rooj, A. K., Lyons, S. M., Ivanov, P. V., Ansari, K. I., Nakano, I., Chiocca, E. A., Godlewski, J. A., & Bronisz, A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.018 · Cited by 198
Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells
Wang, X., Yang, K., Wu, Q., Kim, L. J. Y., Morton, A. R., Gimple, R. C., Prager, B. C., Shi, Y., Zhou, W., Bhargava, S., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau4972 · Cited by 197
Self-citationMéndez, O., Zavadil, J., Esencay, M., Lukyanov, Y., Santovasi, D., Wang, S., Newcomb, E. W., & Zagzag, D. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-133 · Cited by 198
Potential therapeutic implications of cancer stem cells in glioblastoma
Cheng, L., Bao, S., & Rich, J. N. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.035 · Cited by 200
Self-citationCancer Stem Cell Tumor Model Reveals Invasive Morphology and Increased Phenotypical Heterogeneity
Sottoriva, A., Verhoeff, J. J. C., Borovski, T., McWeeney, S. K., Александрович, Н. Л., Medema, J. P., Sloot, P. M. A., & Vermeulen, L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3663 · Cited by 200
HIF1α is required for survival maintenance of chronic myeloid leukemia stem cells
Zhang, H., Li, H., Xi, H. S., & Li, S. (2012) · Blood · doi:10.1182/blood-2011-10-387381 · Cited by 196
HIFs, angiogenesis, and cancer
Yang, Y., Sun, M., Wang, L., & Jiao, B. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24438 · Cited by 193
Glioma Stem Cells: Signaling, Microenvironment, and Therapy
Liebelt, B. D., Shingu, T., Zhou, X., Ren, J., Shin, S., & HU, J. L. (2016) · Stem Cells International · doi:10.1155/2016/7849890 · Cited by 200
Rouault‐Pierre, K., López-Onieva, L., Foster, K., Anjos‐Afonso, F., Lamrissi‐Garcia, I., Serrano-Sanchez, M., Mitter, R., Ivanović, Z., de Verneuil, H., Gribben, J. G., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.08.011 · Cited by 203
DNA damage response – A double-edged sword in cancer prevention and cancer therapy
Tian, H., Gao, Z., Li, H., Zhang, B., Wang, G., Zhang, Q., Pei, D., & Zheng, J. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.12.038 · Cited by 189
Alves, A. L. V., Gomes, I. N. F., Carloni, A. C., Rosa, M. N., da Silva, L. S., Evangelista, A. F., Reis, R. M., & Silva, V. A. O. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02231-x · Cited by 194
Alvarado, A. G., Thiagarajan, P. S., Mulkearns-Hubert, E. E., Silver, D. J., Hale, J. S., Alban, T. J., Turaga, S. M., Jarrar, A., Reizes, O., Longworth, M. S., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2016.12.001 · Cited by 188
Self-citationIncreased Oxidative Stress as a Selective Anticancer Therapy
Liu, J., & Wang, Z. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/294303 · Cited by 191
Dahan, P., Martinez-Gala, J., Delmas, C., Monferran, S., Malric, L., Zentkowski, D., Lubrano, V., Toulas, C., Moyal, E. C., & Lemarié, A. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.509 · Cited by 184
Drug Resistance in Glioblastoma: The Two Faces of Oxidative Stress
Olivier, C., Oliver, L., Lalier-Bretaudeau, L., & Vallette, F. M. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.620677 · Cited by 191
L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1
Cheng, L., Wu, Q., Huang, Z., Guryanova, O. A., Huang, Q., Shou, W., Rich, J. N., & Bao, S. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.10 · Cited by 195
Self-citationGlioma Biology and Molecular Markers
Cohen, A. L., & Colman, H. (2014) · Cancer treatment and research · doi:10.1007/978-3-319-12048-5_2 · Cited by 184
Hypoxia: The Cornerstone of Glioblastoma
Doménech, M., Hernández, A., Plaja, A., Martinez‐Balibrea, E., & Balañá, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212608 · Cited by 187
Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells
Man, J., Yu, X., Huang, H., Zhou, W., Xiang, C., Huang, H., Miele, L., Liu, Z.-G., Bebek, G., Bao, S., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.10.005 · Cited by 188
Self-citationBao, B., Azmi, A. S., Ali, S. S., Ahmad, A., Li, Y., Banerjee, S., Kong, D., & Sarkar, F. H. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.008 · Cited by 182
Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape
Chouaı̈b, S., Messai, Y., Couvé, S., Escudier, B. J., Hasmim, M., & Noman, M. Z. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00021 · Cited by 191
Yang, L., Lin, C., Wang, L., Guo, H., & Wang, X. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.07.017 · Cited by 190
Sullivan, J. P., Minna, J. D., & Shay, J. W. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9216-5 · Cited by 179
DNA Damage Repair Pathways in Cancer Stem Cells
Maugeri‐Saccà, M., Bartucci, M., & Maria, R. D. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-1040 · Cited by 186
Venere, M., Hamerlik, P., Wu, Q., Rasmussen, R. D., Song, L. A., Vasanji, A., Tenley, N., Flavahan, W. A., Hjelmeland, A. B., Bártek, J., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.136 · Cited by 181
Self-citationGuo, X., Xue, H., Shao, Q., Wang, J., Guo, X., Chen, X., Zhang, J., Xu, S., Li, T., Zhang, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11825 · Cited by 172
Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer HeterogeneityPreprint
Martin, J. D., Fukumura, D., Duda, D. G., Boucher, Y., & Jain, R. K. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027094 · Cited by 179
Molecular targeting of hypoxia in radiotherapy
Rey, S., Schito, L., Koritzinsky, M., & Wouters, B. G. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.10.002 · Cited by 178
Modulation of the tumor vasculature and oxygenation to improve therapy
Siemann, D. W., & Horsman, M. R. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.006 · Cited by 169
Radioresistance in Glioblastoma and the Development of Radiosensitizers
Ali, M. Y., Oliva, C. R., Noman, A. S. M., Allen, B. G., Goswami, P. C., Zakharia, Y., Monga, V., Spitz, D. R., Buatti, J. M., & Griguer, C. E. (2020) · Cancers · doi:10.3390/cancers12092511 · Cited by 183
Paul, R., Dorsey, J. F., & Fan, Y. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107985 · Cited by 170
Laminin alpha 2 enables glioblastoma stem cell growth
Lathia, J. D., Li, M., Hall, P. E., Gallagher, J., Hale, J. S., Wu, Q., Venere, M., Levy, E. R., Rani, M. R. S., Huang, P., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23674 · Cited by 175
Self-citationThe cancer stem cell niche(s): The crosstalk between glioma stem cells and their microenvironment
Filatova, A., Acker, T., & Garvalov, B. K. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.10.008 · Cited by 178
Transcription Factors in Cancer Development and Therapy
Vishnoi, K., Viswakarma, N., Rana, A., & Rana, B. (2020) · Cancers · doi:10.3390/cancers12082296 · Cited by 172
Sharma, R., Kadife, E., Myers, M. A., Kannourakis, G., Prithviraj, P., & Ahmed, N. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01961-3 · Cited by 179
Ahmed, N., Escalona, R. M., Leung, D. T. H., Chan, E., & Kannourakis, G. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.10.002 · Cited by 166
The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma
Venere, M., Horbinski, C., Crish, J. F., Jin, X., Vasanji, A., Major, J. A., Burrows, A. C., Chang, C., Prokop, J., Wu, Q., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac6762 · Cited by 162
Self-citationDual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma
Tao, W., Chu, C., Zhou, W., Huang, Z., Zhai, K., Fang, X., Huang, Q., Zhang, A., Wang, X., Yu, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16827-z · Cited by 167
Self-citationDeubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells
Huang, Z., Wu, Q., Guryanova, O. A., Cheng, L., Shou, W., Rich, J. N., & Bao, S. (2011) · Nature Cell Biology · doi:10.1038/ncb2153 · Cited by 165
Self-citationFasting-mimicking diet blocks triple-negative breast cancer and cancer stem cell escape
Salvadori, G., Zanardi, F., Iannelli, F., Lobefaro, R., Vernieri, C., & Longo, V. D. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.10.008 · Cited by 159
MET Signaling Regulates Glioblastoma Stem Cells
Joo, K. M., Jin, J., Kim, E. H., Kim, K. H., Kim, Y., Kang, B. G., Kang, Y.-J., Lathia, J. D., Cheong, K. H., Song, P. H., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3760 · Cited by 164
Self-citationDirect In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells
Lathia, J. D., Gallagher, J., Myers, J. T., Li, M., Vasanji, A., McLendon, R. E., Hjelmeland, A. B., Huang, A. Y., & Rich, J. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024807 · Cited by 158
Self-citationThe adaptive transition of glioblastoma stem cells and its implications on treatments
Wang, Z., Zhang, H., Xu, S., Liu, Z., & Cheng, Q. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00491-w · Cited by 163
Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity
Rasper, M., Schäfer, A., Piontek, G., Teufel, J., Brockhoff, G., Ringel, F. A., Heindl, S., Zimmer, C., & Schlegel, J. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq070 · Cited by 157
Redox Regulation in Cancer Stem Cells
Ding, S., Li, C., Cheng, N., Cui, X., Xu, X., & Zhou, G. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/750798 · Cited by 159
Persano, L., Pistollato, F., Rampazzo, E., Puppa, A. D., Abbadi, S., Frasson, C., Volpin, F., Indraccolo, S., Scienza, R., & Basso, G. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.153 · Cited by 155
Fang, X., Zhou, W., Wu, Q., Huang, Z., Shi, Y., Yang, K., Chen, C., Xie, Q., Mack, S. C., Wang, X., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151673 · Cited by 155
Self-citationAMP kinase promotes glioblastoma bioenergetics and tumour growth
Chhipa, R. R., Fan, Q., Anderson, J., Muraleedharan, R., Huang, Y., Ciraolo, G. M., Chen, X., Waclaw, R. R., Chow, L. M. L., Khuchua, Z. A., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0126-z · Cited by 154
Cancer stem cells in gliomas: Identifying and understanding the apex cell in cancer's hierarchy
Venere, M., Fine, H. A., Dirks, P. B., & Rich, J. N. (2011) · Glia · doi:10.1002/glia.21185 · Cited by 159
Self-citationHe, J., Liu, Y., Zhu, T. S., Zhu, J., DiMeco, F., Vescovi, A. L., Heth, J., Muraszko, K. M., Fan, X., & Lubman, D. M. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010744 · Cited by 152
Truong, D., Fiorelli, R., Barrientos, E. S., Melendez, E. L., Sanai, N., Mehta, S., & Nikkhah, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.048 · Cited by 150
Mao, X., Xue, X., Wang, L., Zhang, X., Yan, M., Tu, Y.-Y., Lin, W., Jiang, X., Ren, H., Zhang, W., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not029 · Cited by 151
Talasila, K. M., Soentgerath, A., Euskirchen, P., Røsland, G. V., Wang, J., Huszthy, P. C., Prestegarden, L., Skaftnesmo, K. O., Sakariassen, P. Ø., Eskilsson, E., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1101-1 · Cited by 153
Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells
Melzer, C., von der Ohe, J., Lehnert, H., Ungefroren, H., & Hass, R. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0595-x · Cited by 152
Targeting a cornerstone of radiation resistance: Cancer stem cell
Moncharmont, C., Lévy, A., Gilormini, M., Bertrand, G., Chargari, C., Alphonse, G., Ardail, D., Rodriguez‐Lafrasse, C., & Magné, N. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.03.024 · Cited by 149
Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance
Najafi, M., Farhood, B., Mortezaee, K., Kharazinejad, E., Majidpoor, J., & Ahadi, R. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-03080-1 · Cited by 151
Myc Posttranscriptionally Induces HIF1 Protein and Target Gene Expression in Normal and Cancer Cells
Doe, M. R., Ascano, J. M., Kaur, M., & Cole, M. D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2371 · Cited by 146
Hypoxia as a biomarker for radioresistant cancer stem cells
Peitzsch, C., Perrin, R. L., Hill, R. P., Dubrovska, A., & Kurth, I. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.916841 · Cited by 143
Nicotinamide metabolism regulates glioblastoma stem cell maintenance
Jung, J., Kim, L. J. Y., Wang, X., Wu, Q., Sanvoranart, T., Hubert, C. G., Prager, B. C., Wallace, L. C., Jin, X., Mack, S. C., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90019 · Cited by 145
Self-citationThe tumour microenvironment, treatment resistance and recurrence in glioblastoma
White, J., White, M. P. J., Wickremesekera, A., Peng, L., & Gray, C. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05301-9 · Cited by 155
Brain tumor stem cells: The cancer stem cell hypothesis writ large
Dirks, P. B. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.08.001 · Cited by 144
Hypoxia Inducible Factor Pathway Inhibitors as Anticancer Therapeutics
Burroughs, S. K., Kaluz, S., Wang, D., Wang, K., Van Meir, E. G., & Wang, B. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.17 · Cited by 140
Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential
Heddleston, J. M., Wu, Q., Rivera, M., Minhas, S., Lathia, J. D., Sloan, A. E., Iliopoulos, O., Hjelmeland, A. B., & Rich, J. N. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.109 · Cited by 142
Self-citationMagnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy
Wankhede, M., Bouras, A., Kaluzová, M., & Hadjipanayis, C. G. (2012) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.1 · Cited by 139
Microenvironmental regulation of cancer metastasis by miRNAs
Zhang, Y., Yang, P., & Wang, X. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.09.007 · Cited by 139
Metabolic features of cancer stem cells: the emerging role of lipid metabolism
Mancini, R., Noto, A., Pisanu, M. E., Vitis, C. D., Maugeri‐Saccà, M., & Ciliberto, G. (2018) · Oncogene · doi:10.1038/s41388-018-0141-3 · Cited by 140
Leone, A., Roca, M. S., Ciardiello, C., Costantini, S., & Budillon, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2597581 · Cited by 137
The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas
Wang, H., Xu, T., Jiang, Y., Xu, H., Yan, Y., Fu, D., & Chen, J. (2015) · Neoplasia · doi:10.1016/j.neo.2015.02.002 · Cited by 145
Self-citationPietras, A., Hansford, L. M., Johnsson, A. S., Bridges, E., Sjölund, J., Gisselsson, D., Rehn, M., Beckman, S., Noguera, R., Navarro, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904606106 · Cited by 135
Tumor Dormancy and Cancer Stem Cells: Two Sides of the Same Coin?
Kleffel, S., & Schatton, T. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-1445-2_8 · Cited by 140
Hypoxia and Hypoxia Inducible Factors in Cancer Stem Cell Maintenance
Li, Z., & Rich, J. N. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_75 · Cited by 140
Self-citationHypoxia induces CD133 expression in human lung cancer cells by up-regulation of OCT3/4 and SOX2
Suzuki, M. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1207 · Cited by 137
Metabolic alterations in cancer cells and therapeutic implications
Hammoudi, N., Ahmed, K. B. R., Garcı́a-Prieto, C., & Huang, P. (2011) · 癌症：英文版 · doi:10.5732/cjc.011.10267 · Cited by 137
Forristal, C. E., Winkler, I. G., Nowlan, B., Barbier, V., Walkinshaw, G., & Lévesque, J.-P. (2012) · Blood · doi:10.1182/blood-2012-02-408419 · Cited by 133
Turner, D. A., & Adamson, D. C. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31820e1152 · Cited by 133
Metadata
- Authors
- Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N.
- Affiliations
- Duke Medical Center (US)
- Cleveland Clinic (US)
- Corresponding author
- Rich, Jeremy N.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 15
- Issue
- 6
- Pages
- 501-513
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC2693960
- OpenAlex
- W2039075677
- Cited by
- 1,354
- References
- 65
- Citations by year
- 2026: 41 · 2025: 40 · 2024: 49 · 2023: 72 · 2022: 92 · 2021: 98 · 2020: 72 · 2019: 75 · 2018: 74 · 2017: 93 · 2016: 97 · 2015: 97 · 2014: 96 · 2013: 80 · 2012: 101
- FWCI
- 30.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA 116659, R01CA116659, CA112958, R01CA129958)
- National Institute of Neurological Disorders and Stroke (K02NS047409, R01NS054276, NS054276, NS047409)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- HIF-2α, glioma stem cells, glioblastoma, hypoxia, angiogenesis, self-renewal, tumor initiation, cancer stem cell markers, patient survival, therapeutic target
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Animals, Brain Neoplasms, Cell Survival, Cells, Cultured, Glioblastoma, Humans, Mice, Inbred BALB C, Mice, Nude, Neoplasm Transplantation, Neovascularization, Pathologic, Stem Cells, Biomarkers, Tumor, Neoplastic Stem Cells, Cell Hypoxia, Vascular Endothelial Growth Factor A, Cell Proliferation, Mice, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
